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Resumo
As fibromatoses profundas do tipo desmoide 
constituem tumores mesenquimatosos raros 
que se caraterizam histologicamente por 
proliferação de fibroblastos e miofibroblastos. 
São caraterísti-cas  destas lesões o crescimento 
infiltrativo e comportamento recidivante, sem 
capacidade de metastização. 
Podem localizar-se na parede abdominal 
(geralmente em locais de suturas), ou em 
topografia intra ou extra-abdominal.
A melhor técnica de imagem para a avaliação 
e estadiamento das fibromatoses profundas é a 
RM. Estas lesões, bem ou mal definidas, exibem 
geralmente bandas internas de hipointensidade 
de sinal, sem captação de contraste (feixes 
de colagéneo) e encontram-se nos planos 
intermuscu-lares com um halo de gordura 
(“split fat sign”), embora invasão dos músculos 
adjacentes seja fre-quente.
Extensão linear ao longo dos planos fasciais 
(o “fascial tail sign”) é igualmente uma 
manifestação frequente das fibromatoses 
profundas e incomum noutras neoplasias de 
tecidos moles.
A intensidade de sinal na RM tem implicação 
na recorrência tumoral, sendo que lesões com 
hipe-rintensidade de sinal em T2 têm maior 
probabilidade de recidiva. Na ausência de excisão 
cirúrgi-ca, em lesões em regime de radioterapia 
ou terapia farmacológica, a RM tem sido usada 
na ava-liação da resposta ao tratamento, com 
resultados favoráveis evidenciando diminuição 
da intensi-dade do sinal T2, da captação de 
contraste e da dimensão da lesão. 
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Abstract
Deep fibromatosis of  desmoid type comprises 
rare mesenchymal tumors characterized 
histologically by proliferation of  fibroblasts and 
myofibroblasts. These lesions are characterized 
by infiltrative growth and local recurrence but 
an inability to metastasize.
They can be located in the abdominal wall 
(generally in sutures), intra or extraabdominal.
The best imaging modality for evaluation 
and staging of  the deep fibromatoses is MR 
imaging. These well or ill-defined lesions 
generally present internal hypointense bands, 
with lack of  enhancement in post contrast 
images (collagen bundles) and are usually 
centered in an intermuscular location with a 
rim of  fat (“split fat sign”), although invasion 
of  surrounding muscle is frequent. Linear 
extension along fascial planes (“fascial tail 
sign”) is also a frequent manifestation in deep 
fibromatoses and is uncommon with other soft-
tissue neoplasms.
MR image signal intensity has an implication 
on tumor recurrence, with a higher recurrence 
rate in lesions with high T2 signal. In surgically 
untreated lesions, with undergoing radiation or 
drug therapy, MR surveillance has been used 
to assess response to treatment with positive 
results demonstrating decrease in T2 signal, 
lesion enhancement and lesion size.
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1. Introduction
1.1 Background
Deep fibromatoses (DF) of  desmoid type, also known 
as desmoid tumors, are rare mesenchymal tumors 
characterized histologically by proliferation of  fibroblasts 
and myofibroblasts.1 They are also composed of  dense 
deposits of  intercellular collagen fibers and variable amounts 
of  extracellular myxoid matrix and vessels.2
DF includes a large group of  fibrous tissue proliferations 
that have intermediate biologic behavior between benign and 
malignant (fibrosarcoma) fibrous lesions. These lesions are 
characterized by infiltrative growth and local recurrence but 
an inability to metastasize.
Classically fibromatoses are divided into superficial 
(palmar, plantar and penile fibromatosis) and deep (DF 
of  desmoid type) forms. (Fig. 1)
The main differential diagnosis of  DF is malignant 
soft-tissue sarcoma, extranodal lymphoma, and benign 
myositis ossificans.
1.2 Deep Fibromatosis (DF) / Desmoid Type 
Fibromatosis
DF (desmoid type fibromatosis) typically manifests as 
a poorly circumscribed soft-tissue mass either in the 
abdominal wall, intra or extraabdominal in location.
This group of  fibromatosis consists of  rapidly growing 
lesions that often reach a large size and have a high 
tendency to recur after treatment, hence the term 
“aggressive fibromatosis”.3
8It tends to occur in patients in the 2nd to 4th decades of  
life, with a peak incidence between 25-35 years of  age. 
Women are more commonly affected than men.
Slow insidious growth is common, and lesions are usually 
painless. Decreased mobility, reduced joint motion and 
neurologic complaints are less frequent symptoms. 
Nevertheless, most patients with DF are asymptomatic and 
these lesions are accidentally identified on imaging studies, 
most often on CT evaluations. (Figs 2, 3 and 4)
Most cases are sporadic, but there is a clear association with 
familial adenomatous polyposis and Gardner’s syndrome, 
suggesting a link with mutations of  the APC gene on 
chromosome 5q22. Approximately 10% of  patients with 
Gardner syndrome also have fibromatosis, which typically 
is of  the intraabdominal type, usually located in the small-
bowel mesentery.1
within the 1st year after delivery and in women who use 
oral contraceptives. The rectus abdominis and internal 
oblique muscles of  the anterior abdominal wall are most 
frequently affected. (Fig. 5)
Figure 1 - Schematic illustration of  the different types of  fibromatosis: 
superficial and deep (desmoid) forms.
Figure 2 - Abdominal wall fibromatosis in a 64-year-old female. Axial CT 
enhanced image showing a well defined nodular enhancing lesion (arrow) 
in the left rectus abdominis muscle.
Intraabdominal DF may be either mesenteric, pelvic or 
retroperitoneal in locations, with similar appearances.
Extraabdominal DF can occur almost anywhere in the 
body, although they have a predilection for the upper torso 
including the upper arm (28%), chest wall/paraspinal 
(17%), and head/neck (10% to 23%). They are typically 
solitary lesions (85%) with a tendency to grow along fascial 
planes and  to extend a great distance from the predominant 
mass.4
Abdominal wall fibromatosis is a distinct variant of  the 
DF as it tends to occur in women during pregnancy or 
Figure 3 - Massive intraabdominal fibromatosis in a 45-year-old male. 
Axial CT image demonstrating a large heterogeneously enhancing 
intraabdominal mass. Note the areas of  less contrast enhancement due to 
increase collagen content and myxoid degeneration (arrow).
Figure 4 - Intraabdominal fibromatosis in a 39-year-old female. Axial 
non-enhanced (a) and enhanced (b) CT images showing a well defined, 
heterogeneously enhancing peritoneal mass. Note the well-defined 
borders of  the lesion (arrow).
92. Imaging Characteristics 
2.1 Conventional Radiography
On conventional radiographs DF is either undetectable 
or identified as an amorphous soft-tissue-density mass. 
Calcification is uncommon. Bone involvement is noted 
in 6%-37% of  cases more frequently after multiple 
recurrences.7
2.2 Ultrasound 
Ultrasound evaluation reveals a hypoechoic lesion either 
ill or well-defined. Color Doppler evaluation is useful in 
demonstrating vascularity of  these lesions although absent 
in 66% of  cases.7
2.3 Computed Tomography
DF can be hypoattenuating, hyperattenuating or appear as 
whorled masses because of  the alternating collagenous and 
myxoid areas. These lesions are well vascularized resulting 
Figure 5 - Abdominal wall fibromatosis in a 37-year-old female. MR images showing a well defined nodular lesion in the left rectus abdominis muscle 
(arrows) with hypointense signal on T1-wheighted images, faint hyperintense signal on T2-weighted images and conspicuous hyperintense signal on fat 
saturated sequences.
in contrast enhancement on CT and MR studies, although 
the degree of  contrast enhancement is variable.7
2.4 MR Imaging
MRI usually depicts a T1 and T2 intermediate signal 
intensity intermuscular centered lesion with a rim of  fat 
(“split fat”sign), although invasion of  surrounding muscle 
is frequent.
Linear extension along fascial planes (the “fascial tail” sign) 
is also a frequent manifestation (80%) and is uncommon in 
other soft-tissue neoplasms.8 (Fig. 6 and 7)
In the majority (86%) of  fibromatoses the T2-weighted 
images depict hypointense bands, with lack of  enhancement 
in post contrast images, that are likely to correspond to 
dense conglomerations of  collagen bundles, a feature that 
is more common in fibromatoses than in other neoplastic 
lesions, although not specific.9,10,11 (Figs. 8, 9, 10, 11, 12, 13, 
14 and 15).
Figure 6 - Aggressive fibromatosis of  the left upper thigh in a 44-year-old female. MR images showing an infiltrative heterogenous lesion with areas of  
low signal intensity in all pulse sequences (arrows). Following gadolinium administration these collagenized bands demonstrate lack of  enhancement.
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Figure 7 - Aggressive fibromatosis in the right upper arm in a 42-year-old female. The lesion is centered in an intermuscular location showing hypointense 
signal on T1-wheighted images, hyperintense signal on fluid sensitive sequences (STIR) and avid gadolinium enhancement. It shows rim of  fat (“split-fat” 
sign, green arrow) and linear extension along fascial planes (“the fascial tail sign”) (blue arrow).
Figure 8 - Intraabdominal fibromatosis (mature form) in a 40-year-old female. MR images showing a well-defined intraabdominal mass anterior to the 
spleen (arrows) with intermediate signal on T1 weighted images and low signal on T2 and T2 FS weighted images.
Figure 9 - Intraabdominal 
fibromatosis (intermediate 
form) in a 57-year-old male. 
MR images showing a well 
defined intraabdominal mass 
(arrows) with intermediate 
signal on T1 weighted images, 
low signal on T2 weighted 
images and slight contrast 
enhancement.
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Although MR imaging can provide clues to the correct 
diagnosis of  aggressive fibromatosis, histologic 
confirmation is required for a final diagnosis in all cases. To 
be noted that MR imaging features similar to fibromatosis 
may occur in pigmented villonodular synovitis, granular cell 
tumor, fibrosarcoma, and malignant fibrous histiocytomas.
Figure 10 - Deep “active” fibromatosis of  the left gluteus muscle in a 
49-year-old male. Axial MR images showing an infiltrative mass in left 
gluteal region with heterogenous low signal intensity on T1-weighted and 
T2-weighted images. High intensity signal areas on T2-weighted images 
(green arrows) and avid enhancement (blue arrows) suggest “active”/first 
stage disease.
Figure 11 - Spinalis muscle fibromatosis in a 59-year-old female. MR images showing a well defined nodular lesion (arrows) in the left spinalis muscle with 
isointense to muscle signal on T1-wheighted images, faint hyperintense signal on T2-weighted images with fat saturation and avid contrast enhancement.
Desmoid type fibromatosis tumors have been described 
as having three stages of  histologic evolution over time as 
they mature:12
• In the first stage, lesions are more cellular with large 
extracellular spaces (which appear as decreased T1 and 
increased T2 MR signal intensity). (Figs. 5, 10, 11, 12, 
13 and 15)
• In the second stage, there is an increase in the amount of  
collagen deposition (which increases the heterogeneity 
of  T2 signal) in the central and peripheral areas of  the 
tumor. (Fig. 9)
• In the final stage there is an increase in the fibrous 
composition (which decreases the T1 and T2 MR 
signal intensity), with a decrease in the volume of  the 
extracellular spaces and water content. (Figs 8 and 14) 
3. Treatment
The preferred treatment is usually wide-local excision.
Adjuvant radiation therapy following surgery has been 
shown to decrease the local recurrence rate versus surgery 
alone.13
Additional therapies with reported positive results include 
radiofrequency ablation and chemotherapy agents. Several 
pharmacological treatments such as hormonal therapy 
(tamoxifen), nonsteroidal anti-inflammatory drugs 
(celecoxib), tyrosine kinase inhibitors such as imatinib or 
sorafenib and cytotoxic chemotherapy have been associated 
with clinical benefit in desmoid patients with progressive 
and/or recurrent disease. Antiestrogen (tamoxifen) and 
anthracycline-containing regimes appear to be associated 
with higher radiological response rates against desmoid 
tumors.14
4. Prognosis
Local recurrence rates are relatively high (50% of  patients 
older than 20 years experiencing a recurrence after local 
excision).15
Signal intensity on long TR sequences may have an 
implication on tumor recurrence, with a higher recurrence 
rate in lesions with high T2 signal.
In lesions undergoing radiation or drug therapy, MR 
surveillance has been used to assess response to treatment 
with a positive response demonstrating a decrease in T2 
signal, lesion enhancement and lesion size.16
12
Figure 12  - Deep fibromatosis in the left deltoid muscle in a 54-year-old male. MR images showing a well defined mass with heterogenous 
intermediate signal intensity on T1-weighted images (isointense to the muscle), high signal intensity on T2- weighted images and avidly enhancing. 
Note the low signal intensity internal areas (arrows) with band like morphology demonstrating lack of  enhancement (characteristic of  fibromatosis).
Figure 13 - Deep fibromatosis of  the left deltoid in a 52-year-old female. Coronal MR images showing a mass centered in the left deltoid muscle 
with isointense signal on T1-wheighted images, faint hyperintense signal on T2-weighted images and avid contrast enhancement. Note the central T2 
-weighted hypointense and non-enchancing collagen bands (arrows).
Figure 14 - Deep fibromatosis 
(late stage) of  the left gluteal 
region in a 34-year-old female. 
MR images showing an 
infiltrative mass centered in the 
left gluteus muscles (arrows) 
with low signal intensity in all 
pulse sequences. Following 
gadolinium administration 
it demonstrates lack of  
enhancement.
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Figure 15 - Deep fibromatosis of  the left masseter muscle in a 43-year-old male. Axial MR images showing a isointense to muscle lesion on T1 weighted 
images, hiperintense in T2weighted images and avid contrast enhancement lesion on the left masseter muscle (arrows). It was biopsy proven to be a deep 
fibromatosis.
5. Conclusion
AF should be included in the differential diagnosis of  a 
soft-tissue mass.
MRI has come to play a crucial role in the management of  
AF, from diagnosis to follow-up. The deep fibromatoses 
are often heterogeneous with internal T2-weighted 
hypointense bands. The “fascial tail” sign and “split fat” 
sign add diagnosis specificity to MR imaging. 
MR imaging can also be useful for determining the response 
to adjuvant radiation therapy or chemotherapy - responding 
lesions show lower T2 signal intensity, decreasing contrast 
enhancement and decreasing dimensions.
6. Main Points
• Fibromatosis can be superficial (palmar, plantar) or 
deep/ aggressive fibromatosis of  desmoid type (either 
in abdominal wall, intraabdominal or extraabdominal 
locations).
• Desmoid type fibromatosis are mesenchymal tumors with 
high tendency to recurrence. 
• While extraabdominal forms can occur almost anywhere 
in the body, they have a predilection for the upper torso, 
including the upper arm, chest wall/paraspinal, and head 
and neck locations.
• The best imaging modality for evaluation and staging of  
the deep fibromatoses is MR imaging.
• Deep fibromatoses may be depicted in MR image with 
non-enhancing T2-weighted hypointense internal bands 
that correspond to collagenous regions seen at histologic 
analysis, with the presence of  “split fat”sign and fascial 
tail sign.
• The signal intensity on T2 MR image is a prognostic 
factor as there is higher recurrence rate in lesions with 
high T2 signal. 
• MR imaging can be useful for determining the response to 
adjuvant radiation therapy or chemotherapy - responding 
lesions show lower T2 signal intensity, decreasing contrast 
enhancement and decreasing dimensions.
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